Stock Options Could no Longer be The Carrot  

Oleh:

Lawrence, Stacy

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 23 no. 2 (Feb. 2005), page 157.
Topik: stock; stock options; carrot

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: NN9.2 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Recruitment of top executives in US biotech companies could soon be hampered by new legislation requiring employee stock option compensation to be treated as an expense, a practice that's close to most accounting standards in Europe. But biotech companies hope that a more lenient rule of delayed enforcement of the new ruling will help to ease the burden on small companies and retain a key incentive in recruiting experinced managers. The new ruling was issued in mid december by the financial accounting standards board (FASB), the designated standard setting organization. Public company reporting should reflect the ruling for the first time by the third quarter of this year. Private companies, also beholden to FASB, are not expected to expense stock options until their annual accounting for the full year of 2005.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali